US
Europe

 

US
Europe

 

missionhistorymanagementboard of directors investors

press releasespress coverageelectronic press kit

media

 

Deutsch

 

enlarged text

 

 

 

Other Projects

Lux Biosciences has a series of additional earlier stage products targeting a range of ophthalmic diseases in which inflammation and the immune system contribute to the disease etiology. These projects will be announced at a later date. The earlier stage projects will be brought forward to the clinic rapidly supported by a strong emphasis on translational research.

© 2008 Lux Biosciences, Inc. All rights reserved.             Web Terms

LX201LX211LX212LX214polymer technologypipeline
other projects

uveitiscorneal transplantationdry eye syndromeage-related macular degeneration

indicationstechnologies

aboutophthalmicproducts &partnersnews &careerscontact us